We are live on
!
Find out more
SELLAS Life Sciences
17 hedge funds and large institutions have $1.39M invested in SELLAS Life Sciences in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
55% more funds holding
Funds holding: 11 → 17 (+6)
0.71% more ownership
Funds ownership: 0.31% → 1.02% (+0.71%)
62% less capital invested
Capital invested by funds: $3.7M → $1.39M (-$2.31M)
Holders
17
Holders Change
+6
Holders Change %
+54.55%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
3
Closed
1
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$57K
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.79M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.67M |
| 3 |
Renaissance Technologies
New York
|
+$1.22M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$518K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$329K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$185K |
| 2 |
BlackRock
New York
|
-$5.68K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$426 |
